🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the pharmacokinetics (PK) ...
Status
Completed
Location
Xuhui Central Hospital
Start Date
2020-10-26
Trial ID
NCT04555733
Treatments Being Tested
This study will look at the effects of lemborexant on Alzheimer's disease b...
Status
Withdrawn
Location
Washington University School of Medicine
Start Date
2023-03-01
Trial ID
NCT05728736
Treatments Being Tested
The purpose of this study is to see if the sleep aid, lemborexant, can decr...
Status
Recruiting
Location
Washington University in St. Louis, School of Medicine
Start Date
2024-03-11
Trial ID
NCT06274528
Treatments Being Tested
E2006-A001-108 is a 4-period crossover study designed to demonstrate that t...
Status
Completed
Location
NeuroTrials Research, Inc
Start Date
2016-11-21
Trial ID
NCT03008447
Part A: The purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
Clinilabs, Inc.
Start Date
2011-10-05
Trial ID
NCT01463098
This study will be conducted to evaluate the effects on cognitive performan...
Status
Completed
Location
Syneos Health
Start Date
2018-03-12
Trial ID
NCT03483636
Treatments Being Tested
The goal of this clinical trial is to learn about how certain medications u...
Status
Recruiting
Location
VCU Institute for Drug and Alcohol Studies
Start Date
2025-05-27
Trial ID
NCT06981195
Treatments Being Tested
The goal of this clinical trial is to learn if Lemborexant works to treat r...
Status
Terminated
Location
St. Michael's Hospital, Unity Health Toronto
Start Date
2024-09-25
Trial ID
NCT06843187
Treatments Being Tested
The goal of this clinical trial is to investigate the 1-month treatment eff...
Status
Not Yet Recruiting
Location
Chulalongkorn University
Start Date
2026-09-01
Trial ID
NCT07683442
This study will be conducted to determine the dose response of lemborexant ...
Status
Completed
Location
Facility #1
Start Date
2016-12-20
Trial ID
NCT03001557